Platelet-rich plasma (PRP) treatment of the ovaries significantly improves fertility parameters and reproductive outcomes in diminished ovarian reserve patients: a systematic review and meta-analysis

被引:12
作者
Elias, Mate [1 ]
Konya, Marton [1 ]
Kekk, Zsofia [1 ]
Turan, Caner [1 ]
das Virgens, Isabel Pinto Amorim [1 ]
Toth, Reka [1 ]
Keszthelyi, Marton [1 ]
Hegyi, Peter [1 ,2 ,3 ]
Varbiro, Szabolcs [1 ]
Sipos, Miklos [1 ,4 ]
机构
[1] Semmelweis Univ, Ctr Translat Med, Budapest, Hungary
[2] Semmelweis Univ, Div Pancreat Dis, Budapest, Hungary
[3] Univ Pecs, Inst Translat Med, Pecs, Hungary
[4] Semmelweis Univ, Ctr Assisted Reprod, Budapest, Hungary
关键词
Platelet-rich plasma; PRP; Diminished ovarian reserve; DOR; Premature ovarian failure; POF; MESENCHYMAL STEM-CELLS; IN-VITRO; WOMEN; INSUFFICIENCY; RESPONDERS; INJECTION; HORMONE; GROWTH; RATS; BETA;
D O I
10.1186/s13048-024-01423-2
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Introduction The incidence of infertility caused by diminished ovarian reserve has become a significant problem worldwide. The beneficial effect of PRP treatment of the ovaries has already been described, but the high-level evidence of its effectiveness has not yet been proven. Materials and methods A systematic search was performed in five databases, until March 12th, 2024. Both randomized and non-randomized studies that compared PRP treatment of the ovaries to self-control among women with diminished ovarian reserve were eligible for inclusion. Hormonal levels (Anti-M & uuml;llerian hormone (AMH), Follicle stimulating hormone (FSH), Luteinizing hormone (LH), Estradiol (E2), In-vitro fertilization parameters (Antral follicle count, oocyte, and embryo count), biochemical and spontaneous pregnancy and livebirth were measured. Results 38 eligible studies were identified reporting on 2256 women. The level of AMH rised, the level of FSH decreased significantly after the PRP treatment. AMH 1 month MD 0.20 (n = 856, p > 0.001, 95% CI: [0.12;0.28]), 2 months MD 0.26 (n = 910, p = 0.013, 95% CI: [0.07;0.44]), 3 months MD 0.36 (n = 881, p = 0.002,95% CI: [0.20;0.52]). FSH 1 month MD -10.20 (n = 796, p > 0.039, 95% CI: [-19.80;-0.61]), 2 months MD -7.02 (n = 910, p = 0.017, 95% CI: [-12.48; -1.57]), 3 months MD -8.87 (n = 809, p = 0.010, 95% CI: [-14.19; -3.55]). The antral follicle count elevated significantly MD 1.60 (n = 1418, p = < 0.001, 95% CI: [0.92; 2.27]). Significant improvement was observed in the number of retrieved oocytes MD 0.81 (n = 802, p = 0.002, 95% CI: [0.36; 1.26]), and embryos created MD 0.91 (n = 616, p = 0.001, 95% CI: [0.45;1.36]). The incidence of spontaneous pregnancy following PRP treatment showed a rate with a proportion of 0.07 (n = 1370, 95% CI: 0.04-0.12), the rate of biochemical pregnancy was 0.18 (n = 1800, 95% CI: 0.15-0.22), livebirth was 0.11 (n = 1482, 95% CI: 0.07-0.15). Conclusions Our meta-analysis showed that based on protocolized analysis of the widest scientific literature search to date, containing predominantly observational studies, PRP treatment resulted in a statistically significant improvement in the main fertility parameters of diminished ovarian reserve women. Further multicenter, randomized trials, with large patient numbers and a longer follow-up period are needed to certify our results and develop the most effective treatment protocol.
引用
收藏
页数:18
相关论文
共 89 条
[1]  
Abdullah TH., 2019, Indian J Public Health Res Dev, DOI [10.5958/0976-5506.2019.02060.6, DOI 10.5958/0976-5506.2019.02060.6]
[2]   Effects of Intraovarian Injection of Autologous Platelet-Rich Plasma on Ovarian Rejuvenation in Poor Responders and Women with Primary Ovarian Insufficiency [J].
Aflatoonian, Abbas ;
Lotfi, Marzieh ;
Saeed, Lida ;
Tabibnejad, Nasim .
REPRODUCTIVE SCIENCES, 2021, 28 (07) :2050-2059
[3]  
Agarwal R., 2023, J South Asian Fed Obstet Gynaecol, V15, P601
[4]   Intra-ovarian injection of platelet-rich plasma into ovarian tissue promoted rejuvenation in the rat model of premature ovarian insufficiency and restored ovulation rate via angiogenesis modulation [J].
Ahmadian, Shahin ;
Sheshpari, Sepideh ;
Pazhang, Mohammad ;
Bedate, Alberto Miranda ;
Beheshti, Rahim ;
Abbasi, Mehran Mesgari ;
Nouri, Mohammad ;
Rahbarghazi, Reza ;
Mahdipour, Mahdi .
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2020, 18 (01)
[5]   Functional and Structural Assessment of the Possible Protective Effect of Platelet-Rich Plasma against Ischemia/Reperfusion-Induced Ovarian Injury in Adult Rats [J].
Allam, Eman Ahmed ;
Moniem, Rehab Ahmed Abdel ;
Soliman, Gehan Yassin .
CHINESE JOURNAL OF PHYSIOLOGY, 2022, 65 (02) :64-71
[6]   A Review of Platelet-Rich Plasma: History, Biology, Mechanism of Action, and Classification [J].
Alves, Rubina ;
Grimalt, Ramon .
SKIN APPENDAGE DISORDERS, 2018, 4 (01) :18-24
[7]  
[Anonymous], OECD Family Database: Public Spending on Education
[8]   Chemoprotective effects of plasma derived from mice of different ages and genders on ovarian failure after cyclophosphamide treatment [J].
Bahmanpour, Soghra ;
Moradiyan, Eisa ;
Dehghani, Farzaneh ;
Zarei-fard, Nehleh .
JOURNAL OF OVARIAN RESEARCH, 2020, 13 (01)
[9]   Preliminary report of intraovarian injections of autologous platelet-rich plasma (PRP) in extremely poor prognosis patients with only oocyte donation as alternative: a prospective cohort study [J].
Barad, D. H. ;
Albertini, D. F. ;
Molinari, E. ;
Gleicher, N. .
HUMAN REPRODUCTION OPEN, 2022, 2022 (03)
[10]   Intraovarian platelet-rich plasma injection and IVF outcomes in patients with poor ovarian response: a double-blind randomized controlled trial [J].
Barrenetxea, G. ;
Celis, R. ;
Barrenetxea, J. ;
Martinez, E. ;
de las Heras, M. ;
Gomez, O. ;
Aguirre, O. .
HUMAN REPRODUCTION, 2024, 39 (04) :760-769